Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correlation between staging classification of aortic stenosis based on the extent of cardiac damage and platelet indices.
Maller T, Bruoha S, Loutati R, Carasso S, Taha L, Sabouret P, Galli M, Zoccai GB, Spadafora L, Dvir D, Shuvy M, Jubeh R, Marmor D, Perel N, Levi N, Amsalem I, Hitter R, Shrem M, Glikson M, Asher E; Jerusalem Platelets Thrombosis, Intervention in Cardiology (JUPITER-17) Study Group. Maller T, et al. Among authors: spadafora l. BMC Cardiovasc Disord. 2024 Oct 14;24(1):555. doi: 10.1186/s12872-024-04246-7. BMC Cardiovasc Disord. 2024. PMID: 39402456 Free PMC article.
Mitophagy modulation for the treatment of cardiovascular diseases.
Forte M, D'Ambrosio L, Schiattarella GG, Salerno N, Perrone MA, Loffredo FS, Bertero E, Pilichou K, Manno G, Valenti V, Spadafora L, Bernardi M, Simeone B, Sarto G, Frati G, Perrino C, Sciarretta S; Italian Society of Cardiology Working Group on Cellular and Molecular Biology of the Heart. Forte M, et al. Among authors: spadafora l. Eur J Clin Invest. 2024 Aug;54(8):e14199. doi: 10.1111/eci.14199. Epub 2024 Mar 26. Eur J Clin Invest. 2024. PMID: 38530070 Review.
Should SGLT2 inhibitors be prescribed in all diabetic type 2 patients?
Bernardi M, Spadafora L, Galli M, Biondi-Zoccai G, Sabouret P. Bernardi M, et al. Among authors: spadafora l. Arch Med Sci. 2023 Feb 3;19(2):528-531. doi: 10.5114/aoms/160006. eCollection 2023. Arch Med Sci. 2023. PMID: 37034516 Free PMC article. No abstract available.
New approaches to reduce recurrent PCI: to angioplasty and beyond!
Sabouret P, Manzo-Silberman S, Alasnag M, Fysekidis M, Gulati M, Galati G, Spadafora L, Banach M, Biondi-Zoccai G, Bhatt DL. Sabouret P, et al. Among authors: spadafora l. Eur Heart J Open. 2023 May 17;3(3):oead049. doi: 10.1093/ehjopen/oead049. eCollection 2023 May. Eur Heart J Open. 2023. PMID: 37273260 Free PMC article. Review. No abstract available.
Treatment adherence in patients without ST-elevation acute coronary syndrome.
Campos Cervera LV, Sabouret P, Bernardi M, Spadafora L, Banach M, Muñoz F, Viruel M, Zaidel EJ, Bonorino J, Perez G, Arbucci R, Costabel JP. Campos Cervera LV, et al. Among authors: spadafora l. Minerva Cardiol Angiol. 2024 Apr;72(2):134-140. doi: 10.23736/S2724-5683.23.06345-7. Epub 2023 Jul 5. Minerva Cardiol Angiol. 2024. PMID: 37405714
Impact of ethnicity on antiplatelet treatment regimens for bleeding reduction in acute coronary syndromes: a systematic review and pre-specified subgroup meta-analysis.
Galli M, Laborante R, Occhipinti G, Zito A, Spadafora L, Biondi-Zoccai G, Nerla R, Castriota F, D'Amario D, Capodanno D, Jeong YH, Kimura T, Mehran R, Angiolillo DJ. Galli M, et al. Among authors: spadafora l. Eur Heart J Cardiovasc Pharmacother. 2024 Feb 23;10(2):158-169. doi: 10.1093/ehjcvp/pvad085. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 37960983
104 results